Inactive Instrument

Press Releases Amarantus Bioscience Holdings Inc OTC Bulletin Board

Equities

AMBS

US02300U1060

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2022	Sector Update: Financial Stocks Still Adding to Wednesday Declines	MT
2020	Todos Medical Ltd. (OTCPK:TOMD.F) completed the acquisition of remaining 80.01% stake in Breakthrough Diagnostics Inc. from Amarantus BioScience Holdings, Inc.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amarantus BioScience : Notification of Late Filing	21-11-18	PU
Amarantus BioScience : Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus	20-07-28	AQ
Emerald Organic Products : Restructures Joint Venture Agreement With Todos Medical by Entering Joint Collaboration Agreement	20-05-08	AQ
Amarantus BioScience : Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel	20-03-17	AQ
Amarantus BioScience : Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International	20-02-06	AQ
Amarantus Releases Letter to Shareholders	20-02-04	GL
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori	20-01-30	GL
Emerald Organic Products : Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products	20-01-02	AQ
Amarantus to Present at 12th Annual LD Micro Main Event	19-12-09	GL
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease	19-12-04	GL
Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics	19-11-21	GL
Amarantus Provides Recapitalization Update to Shareholders	19-11-18	GL
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products	19-10-24	GL
Amarantus Bioscience : Provides Comprehensive Corporate Update	17-12-01	PR
Amarantus Bioscience : Enters Into Forbearance and Capital Restructuring Agreements With Holders of Secured Debt, Convertible Preferred Stock and Warrants	17-11-17	PR
Amarantus Bioscience : Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.	17-04-05	PR
Amarantus Bioscience : Completes Sale of Diagnostics Division, Announces Fiscal Year 2015 and First Quarter 2016 Financial Results	16-06-03	PR
Amarantus Bioscience : Announces Capital Infusion	16-04-21	PR
Amarantus Bioscience : Announces Cancellation of Special Meeting of Shareholders	16-03-22	PR
Amarantus Bioscience : Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health	16-03-07	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amarantus Bioscience Holdings Inc OTC Bulletin Board

Equities

AMBS

US02300U1060

Press Releases

Filters